U. S. Department of Health, Education, and Welfare
FOOD AND DRUG ADMINISTRATION
NOTICES OF JUDGMENT UNDER THE FEDERAL FOOD,
DRUG, AND COSMETIC ACT
[Given pursuant to section 705 of the Food, Drug, and Cosmetic Act]
3861-3880
DRUGS AND DEVICES
The cases reported herewith were instituted in the United States district
courts by the United States attorneys, acting upon reports submitted by the U. S.
Department of Health, Education, and Welfare, and include, where indicated, the
results of investigations by the Department, prior to the institution of the pro-
ceedings.   Published by direction of the Secretary of Health, Education, and
Welfare.
CHARLES W. CRAWFORD, Commissioner of Food and Drugs.
WASHINGTON, D. C, May 14,1953.
CONTENTS *
Page
New drug shipped without effective
application 
_ 358
Drug for veterinary use 
358
Violative    sales    of    prescription
drugs 
358
Drugs and devices actionable be-
cause of failure to bear ade-
quate directions or warning
statements 
359
Drugs actionable because of con-
tamination with filth 
364
Page
Drugs actionable because of devia-
tion from official or own stand-
ards 
365
Drugs actionable because of false
and misleading claims 
366
Drugs for human use 
 366
Drugs for veterinary use 
370
Index 
371
*For drug actionable because of potential danger when used according to directions, see No. 3861 (veteri-
nary preparation); presence of a habit-forming narcotic without warning statement, Nos. 3863-3866; omission
of, or unsatisfactory, ingredients statements, Nos. 3861 (veterinary preparation), 3864, 3865, 3867; imitation
of, and sale under name of, another drug, No. 3867; failure to bear a label containing an accurate statement
of the quantity of the contents, Nos. 3863-3867; failure to bear a label containing the name and place of
business of the manufacturer, packer, or distributor, Nos. 3863, 3865-3867.
357
250655-53-
NEW DRUG SHIPPED WITHOUT EFFECTIVE APPLICATION
DRUG FOR VETERINARY USE
3861. Adulteration and misbranding of Wonder mange capsules.   U. S. v. John   /"
M. Adams.   Plea of guilty.   Defendant placed on probation for 2 years,    v
(F. D. C. No. 32708.   Sample Nos. 21028-L, 21212-L, 29044-L.)
INFORMATION FILED : June 6, 1952, Northern District of Alabama, against John
M. Adams, manager of the J. Q. Adams Drug Co., Ashland, Ala.
ALLEGED SHIPMENT: On or about March 15 and April 25, 1951, from the State
of Alabama into the States of Texas and Oregon.
LABEL, IN PART: "Wonder Mange Capsules (Canine) Caution:-Not for Human
Use   Each capsule contains 10 grains Sodium 2 Arsenious Acid."
NATURE OF CHARGE: Section 505 (a), the article was a new drug within the
meaning of the law, and an application filed pursuant to the law was not
effective with respect to the article.
Adulteration, Section 501 (c), the strength of the article differed from that
Which it purported and was represented to possess since it purported and was
represented to contain 10 grains of a sodium compound of arsenious acid in
each capsule, whereas the article did not contain 10 grains of a sodium com-
pound of arsenious acid in each capsule but contained in excess of 10 grains
of arsenic trioxide in each capsule.
Misbranding, Section 502 (a), the label statement "Each capsule contains
10 grains Sodium 2 Arsenious Acid" was false and misleading since the article
contained in excess of 10 grains of arsenic trioxide in each capsule, and the
label statements "Wonder Mange Capsules (Canine)" and "Uses: These cap-
sules may be used in the treatment of All Types of Mange On Dogs" were false
and misleading since the statements represented and suggested that the article
would be effective in the treatment of all types of mange on dogs, whereas it
would not be effective in the treatment of any type of mange on dogss
Further misbranding, Section 502 (e) (1), the article was not designated
solely by a name recognized in an official compendium, and its label failed to
bear the common or usual name of the article, namely, arsenic trioxide; and,
Section 502 (j), the article was dangerous to health when used in the dosage
and with the frequency and duration prescribed, recommended, and suggested
in the labeling, namely, "Dogs over 10 pounds body weight should receive one
capsule every 3 days until symptoms disappear."
DISPOSITION : October 24,1952. A plea of guilty having been entered, the court
placed the defendant on probation for 2 years.
VIOLATIVE SALES OF PRESCRIPTION DRUGS